We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pecan-Enriched Diet Protects against CV Disease and Diabetes

By LabMedica International staff writers
Posted on 03 Apr 2018
Results of a randomized, controlled feeding trial suggested that eating just 1.5 ounces (44.36 milliliters) of pecans every day could protect adults at risk for developing cardiovascular disease (CVD) and type II diabetes.

Evidence from observational and intervention studies has shown that a high intake of tree nuts was associated with a reduced risk of cardiovascular disease (CVD), mortality from type II diabetes, and all-cause mortality. More...
However, there is limited data available regarding the dietary effects of tree nuts on indicators of cardiometabolic risk other than hypercholesterolemia, and little is known about the demonstrable health benefits of pecans.

To fill this gap, investigators at Tufts University (Boston, MA, USA) conducted a randomized, controlled feeding trial to compare the effects of a pecan-rich diet with a control diet containing similar total fat and fiber content, but lacking nuts, on biomarkers related to CVD and type II diabetes risk in healthy middle-aged and older adults who were overweight or obese with excess belly fat.

Results published in the March 11, 2018, online edition of the journal Nutrients revealed that after four weeks on a pecan-rich diet, changes in serum insulin, insulin resistance, and pancreatic beta cell function were significantly greater than after the control diet. Pecan consumption also lowered the risk of cardiometabolic disease as indicated by a composite score reflecting changes in clinically relevant markers. Thus, compared to the control diet, the pecan intervention had a concurrent and clinically significant effect on several relevant markers of cardiometabolic risk.

"Pecans are naturally high in monounsaturated and polyunsaturated fats, so replacing a portion of the saturated fat in the diet with these healthier fats can explain some of the cardio-protective effects we observed," said first author Dr. Diane McKay, assistant professor of nutrition science at Tufts University. "But pecans also contain a number of bioactive plant compounds as well as vitamins and essential minerals that all likely contributed to this benefit. What is really interesting is that just one small change - eating a handful of pecans daily - may have a large impact on the health of these at-risk adults."

Related Links:
Tufts University


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Portable Electronic Pipette
Mini 96
8-Channel Pipette
SAPPHIRE 20–300 µL
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.